MedPath

A clinical study on the effect of glycopyrrolate on the maternal blood pressure and vasopressor requirement during cesarean delivery

Not Applicable
Completed
Conditions
Health Condition 1: O82- Encounter for cesarean delivery without indication
Registration Number
CTRI/2020/12/029495
Lead Sponsor
JSS Medical College and Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

Height- 150-170cm

Body mass index < 28kg/m2

Singleton pregnancy

Exclusion Criteria

Patients having contraindications to spinal anaesthesia i.e, patient refusal, local infection, allergy to local anaesthetics, bleeding disorders, spinal deformity, severe congenital or acquired heart disease, hemorrhage or hypovolemic shock (each condition ruled out via good history, clinical examination, & or investigations)

Known sensitivity to the study drugs

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The incidence of hypotension and vasopressor requirement during spinal anaesthesia for cesarean deliveryTimepoint: Hypotension is assessed from 1 minute after administration of spinal anaesthesia up to 60 minutes or end of surgery whichever is the earliest. <br/ ><br>Total amount IV Ephedrine 6mg given intra-operative period from 1 minute of spinal-anaesthesia administration up to the end of surgery.
Secondary Outcome Measures
NameTimeMethod
Incidence of bradycardia and requirement of atropine <br/ ><br>Incidence of nausea, vomiting and dryness of mouth. <br/ ><br>Time for onset , maximum level and duration of sensory block <br/ ><br>Time for 2 segment regression of sensory block <br/ ><br>Time for onset of motor block, maximum level and duration of motor block <br/ ><br>APGAR score <br/ ><br>Timepoint: Bradycardia below 60 beats/min. Effect of spinal anesthesia on motor and sensory blockade.
© Copyright 2025. All Rights Reserved by MedPath